Top Story

Atrial septal closure device explant may resolve nickel allergy symptoms

May 22, 2015

SAN DIEGO — Patients with nickel allergy and severe refractory symptoms after implantation with an atrial septal closure device experienced complete resolution of symptoms after device explantation, according to a report presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

Divya Ratan Verma, MD, MS, from University of Utah Hospitals and Clinics, said a small number of patients with cardiac pathology who are implanted with biomedical devices may experience allergic reactions to nickel as the device corrodes, releasing nickel particles that trigger immune response. The systemic reaction typically presents with chest pain, exertional dyspnea, asthenia and mild leukocytosis, with other symptoms including migraine and pericarditis.

Evolocumab recommended for approval in Europe

May 22, 2015
Amgen announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the marketing authorization…
Arnold Greenspon, MD In the Journals

Repeat revisions for ICDs, CRT-Ds linked to substantial costs

May 22, 2015
When a patient with an implantable cardioverter defibrillator or a cardiac resynchronization therapy defibrillator undergoes more than one revision procedure…
Meeting News Coverage

High-intensity statin use low in patients with diabetes, high CVD risk

May 22, 2015
NASHVILLE, Tenn. - Patients with type 2 diabetes at very high risk for cardiovascular disease are often not taking high-intensity statins, further increasing their risk…
Vivek Y. Reddy, MD Meeting News CoveragePerspective

SELECT-LV: Wireless LV endocardial pacing may benefit CRT nonresponders

May 22, 2015
BOSTON — A wireless left ventricular endocardial pacing system could be a viable alternative for patients with HF in whom cardiac resynchronization therapy is not…
More News Headlines »
CME
Examining Diverse Patient Populations and Their Response to Therapy

Examining Diverse Patient Populations and Their Response to Therapy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
Meeting News Coverage Video
VIDEO: Community awaits PCSK9 inhibitor phase 3 results, approval

VIDEO: Community awaits PCSK9 inhibitor phase 3 results, approval

May 17, 2015
SAN DIEGO — C. Noel Bairey Merz, MD, FACC, director of the Barbra Streisand Women’s Heart Center in the…
More »
CME
Opening the Window of Time in Stroke Therapy: New Evidence for the Emergency Department

Opening the Window of Time in Stroke Therapy: New Evidence for the Emergency Department

This activity is supported by an educational grant from Genentech, Inc.

The Centers for Disease Control and Prevention report an annual 130,000 stroke-related fatalities in the United States…
More »
morganatic-roan